Autor der Publikation

Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis

, , , und . (September 2020)
DOI: 10.1101/2020.09.30.20204693

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras, , , , , und . (Juli 2021)Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection, , , , , und . Reviews in Cardiovascular Medicine, 21 (4): 611 (2020)A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products, und . Current Problems in Cardiology, (2021)Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection, , , , , , , , , und 13 andere Autor(en). The American Journal of Medicine, 134 (1): 16 - 22 (2021)Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis, , , und . (September 2020)Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients, , , , , , und . (Juli 2021)Frequentist and Bayesian analysis methods for case series data and application to early outpatient COVID-19 treatment case series, , und . (März 2022)Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents, , , , , , , , , und 1 andere Autor(en). (Februar 2021)COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign, , , , , , und . Cureus, (Januar 2024)Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19), , , , , , , , , und 49 andere Autor(en). Reviews in Cardiovascular Medicine, 21 (4): 517 (2020)